Comparative studies on tissue transglutaminase and factor XIII
No abstract listed.
Transglutaminase from hair follicle of guinea pig (crosslinking-fibrin-glutamyllysine-isoenzymes-purified enzyme)
Transglutaminase: mechanistic features of the active site as determined by kinetic and inhibitor studies
Wound healing at the site of microvascular anastomosis: fibrin-stabilizing factor XIII administration and its effects
Effect of retinoic acid on liver transglutaminase activity and carbon tetrachloride-induced liver damage in mice
Transglutaminase may mediate certain physiological effects of endogenous amines and of amine-containing therapeutical agents
Stimulation by acetylcholine and inhibition by norepinephrine of transglutaminase activity in superior cervical ganglia excised from adult rats
Factor XIII activity levels in patients with allogeneic haematopoietic stem cell transplantation and acute graft-versus-host disease of the gut
Specific fluorescent labeling of chicken myofibril Z-line proteins catalyzed by guinea pig liver transglutaminase
Whole-Genome Shotgun Assembly and Analysis of the Genome of Streptomyces mobaraensis DSM 40847, a Strain for Industrial Production of Microbial Transglutaminase
Localization of the gene for coagulation factor XIII a-chain to chromosome 6 and identification of sites of synthesis
Hemopoietic origin of factor XIII A subunits in platelets, monocytes, and plasma. Evidence from bone marrow transplantation studies
Deficiency of coagulation factor XIII A subunit caused by the dinucleotide deletion at the 5' end of exon III
Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system
Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length
Keratinocyte-specific transglutaminase of cultured human epidermal cells: relation to cross-linked envelope formation and terminal differentiation
FXIII induced gelation of human fibrinogen--an alternative thiol enhanced, thrombin independent pathway
Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function
Identification of the eukaryotic initiation factor 5A as a retinoic acid-stimulated cellular binding partner for tissue transglutaminase II.
Pellicle precursor protein crosslinking characterization of an adduct between acidic proline-rich protein (PRP-1) and statherin generated by transglutaminase
The proximal promoter of the human transglutaminase 3 gene. Stratified squamous epithelial-specific expression in cultured cells is mediated by binding of Sp1 and ets transcription factors to a proximal promoter element
Effects of transglutaminase substrates and inhibitors on the motility of demembranated reactivated spermatozoa
Coordination of keratinocyte programming in human SCC-13 squamous carcinoma and normal epidermal cells
Rat gastrointestinal transglutaminase: demonstration of enzyme activity and cell and tissue distributions
Purification and on-column activation of a recombinant histidine-tagged pro-transglutaminase after soluble expression in Escherichia coli
Analysis of factor XIII substrate specificity using recombinant human factor XIII and tissue transglutaminase chimeras.
Biochemical effects of retinoic acid on GTP-binding Protein/Transglutaminases in HeLa cells. Stimulation of GTP-binding and transglutaminase activity, membrane association, and phosphatidylinositol lipid turnover.
Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability
Blood Clotting Disorders
Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.